Home | All results_reference

[RDF data]
Results Reference #1138

Resource URI: http://static.linkedct.org/resource/results_reference/1138
linkedct:citation Matei D, Sill MW, DeGeest K, et al.: Phase II trial of sorafenib in persistent or recurrent epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC): A Gynecologic Oncology Group (GOG) study. [Abstract] J Clin Oncol 26 (Suppl 15): A-5537, 2008.
rdfs:label Results Reference #1138
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00093626>
linkedct:results_reference_id 1138 (xsd:int)
rdf:type linkedct:results_reference